摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-methyl-5,6,7,8-tetrahydroquinoxaline 1,4-dioxide | 76443-20-4

中文名称
——
中文别名
——
英文名称
2-methyl-5,6,7,8-tetrahydroquinoxaline 1,4-dioxide
英文别名
2-Methyl-5,6,7,8-tetrahydroquinoxaline 1,4-di-oxide;3-methyl-4-oxido-5,6,7,8-tetrahydroquinoxalin-1-ium 1-oxide
2-methyl-5,6,7,8-tetrahydroquinoxaline 1,4-dioxide化学式
CAS
76443-20-4
化学式
C9H12N2O2
mdl
——
分子量
180.206
InChiKey
ADLOXEZTKMBZQC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.1
  • 重原子数:
    13
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.56
  • 拓扑面积:
    46.4
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    2-乙氧基丙-2-烯醛2-(hydroxyamino)cyclohexanone oxime hydroacetate盐酸 作用下, 以 为溶剂, 反应 30.0h, 以10%的产率得到2-methyl-5,6,7,8-tetrahydroquinoxaline 1,4-dioxide
    参考文献:
    名称:
    Reaction of 2-Alkoxypropenals with α-Hydroxyamino Oximes and 1,2-Bis(hydroxyamino)cyclohexane
    摘要:
    2-烷氧丙烯醛与α-羟基氨基肟在中性介质中的反应涉及前者的醛基,生成无环和环状的亚胺氧化物:N-(2-羟基亚胺烷基)-N-(2-烷氧基-2-丙烯基)胺氧化物和1-羟基-2,5-二氢咪唑-3-氧化物。环状和无环产物之间的并置平衡状态取决于溶剂的性质和温度。在酸性水相中反应伴随着2-烷氧基丙烯醛中乙烯醚部分的水解,形成2-氧丙醛,该醛与α-羟基氨基肟在羟基氨基组上反应,生成取代的吡嗪1,4-二氧化物。2-烷氧丙烯醛与1,2-双(羟基氨基)环己烷的反应生成2-(1-烷氧基乙烯基)-1,3-二羟基全氟苯并咪唑。产品的结构通过红外光谱、紫外光谱、1H和13C核磁共振光谱以及X射线分析得到了验证。
    DOI:
    10.1007/s11178-005-0361-1
点击查看最新优质反应信息

文献信息

  • VOLODARSKIJ L. B.; AMITINA S. A.; DULEPOVA N. V., IZV. AN CCCP CEP. XIM., 1979, HO 4, 904-907
    作者:VOLODARSKIJ L. B.、 AMITINA S. A.、 DULEPOVA N. V.
    DOI:——
    日期:——
  • GRIGOREVA, L. N.;TIXONOV, A. YA.;AMITINA, S. A.;VOLODARSKIJ, L. B.;KOROBE+, XIMIYA GETEROTSIKL. SOEDIN., 1986, N 3, 331-338
    作者:GRIGOREVA, L. N.、TIXONOV, A. YA.、AMITINA, S. A.、VOLODARSKIJ, L. B.、KOROBE+
    DOI:——
    日期:——
  • Reaction of 2-Alkoxypropenals with α-Hydroxyamino Oximes and 1,2-Bis(hydroxyamino)cyclohexane
    作者:N. A. Keiko、E. A. Funtikova、L. I. Larina、G. I. Sarapulova、D. G. Mazhukin、T. V. Rybalova、A. Ya. Tikhonov
    DOI:10.1007/s11178-005-0361-1
    日期:2005.10
    Reactions of 2-alkoxypropenals with α-hydroxyamino oximes in neutral medium involve the aldehyde group of the former to afford both acyclic and cyclic azomethine oxides: N-(2-hydroxyiminoalkyl)-N-(2-alkoxy-2-propenylidene)amine oxides and 1-hydroxy-2,5-dihydroimidazole 3-oxides. The state of tautomeric equilibrium between the cyclic and acyclic products depends on the solvent nature and temperature. The reaction in acidic aqueous medium is accompanied by hydrolysis of the vinyl ether moiety in 2-alkoxy-propenals with formation of 2-oxopropionaldehyde which reacts with α-hydroxyamino oxime at the hydroxy-amino group to give substituted pyrazine 1,4-dioxides. The reaction of 2-alkoxypropenals with 1,2-bis-(hydroxyamino)cyclohexane leads to formation of 2-(1-alkoxyvinyl)-1,3-dihydroxyperhydrobenzimidazoles. The structure of the products was proved by IR, UV, and 1H and 13C NMR spectroscopy and X-ray analysis.
    2-烷氧丙烯醛与α-羟基氨基肟在中性介质中的反应涉及前者的醛基,生成无环和环状的亚胺氧化物:N-(2-羟基亚胺烷基)-N-(2-烷氧基-2-丙烯基)胺氧化物和1-羟基-2,5-二氢咪唑-3-氧化物。环状和无环产物之间的并置平衡状态取决于溶剂的性质和温度。在酸性水相中反应伴随着2-烷氧基丙烯醛中乙烯醚部分的水解,形成2-氧丙醛,该醛与α-羟基氨基肟在羟基氨基组上反应,生成取代的吡嗪1,4-二氧化物。2-烷氧丙烯醛与1,2-双(羟基氨基)环己烷的反应生成2-(1-烷氧基乙烯基)-1,3-二羟基全氟苯并咪唑。产品的结构通过红外光谱、紫外光谱、1H和13C核磁共振光谱以及X射线分析得到了验证。
查看更多

同类化合物

N,N-二氧化吡嗪 5-异丙基-2,3-二甲基吡嗪1,4-二氧化物 3-甲基-4-氧代吡嗪-1-鎓1-氧化物 2-甲基-2-亚硝基丙腈 2,5-二甲基吡嗪 1,4-二氧化物 2,3-二氢-3,3-二甲基-吡嗪醇 1,4-二氧化物 2,3,3,5,6-五甲基-1-氧代-2,3-二氢吡嗪-1-鎓-4(1H)-醇 2,2,3,3,5,6-六甲基-1-羰基-2,3-二氢吡嗪-1-正离子-4(1H)-醇酸 1,2-二[1-(1,1-二甲基乙基)-2,2-二甲基丙基]二氮烯1,2-二氧化物 (5-甲基-1,4-二氧代-2-吡嗪基)甲醇 trans-Nitrosomethan-dimer 1,2-Bis(2,2-diethoxyethyl)-2-oxodiazan-2-ium-1-olate nitrosocyclohexane dimer Dimeres-2-Chlor-1-nitroso-cyclopentan 2,5-Dichlor-3,6-diethylpyrazin-1,4-dioxid [Oxido(propan-2-yl)amino]-oxo-propan-2-ylazanium Tetrachlorpyrazin-bis-N-oxid Bis-(5-methyl-hexa-3,4-dienyl)-diazene N,N'-dioxide 2,3,4,6,7,8,9,10-Octahydro-1H-cyclohepta[b]quinoxaline 5,11-dioxide 2,7-Dicyano-2,7-dimethyl-3,6-diazaocta-3,5-dien-3,6-dioxide 2,3-Dimethyl-4a,5,6,7,8,8a-hexahydro-quinoxaline 1,4-dioxide 3-(2-Methoxyethoxy)-4-oxidopyrazin-1-ium 1-oxide 2-propylpyrazine 1,4-dioxide 2-methyl-5,6,7,8-tetrahydroquinoxaline 1,4-dioxide 1-nitrosodecane dimer 2,2,3,3-Tetramethyl-2,3-dihydropyrazin-1,4-dioxid 2,6-dimethylpyrazine-N,N'-dioxide 2,3-dimethylpyrazine 1,4-dioxide 2,5-Dichlor-3,6-dimethylpyrazin-1,4-dioxid 2,5-di-iso-propylpyrazine 1,4-dioxide 2,3,5-trimethylpyrazine-N,N'-dioxide 2-methoxymethyl-5-methylpyrazine-1,4-dioxide 3-hydroxy-2,2-dimethyl-2,3,5,6,7,8-hexahydroquinoxaline 1,4-dioxide 1,2-Bis(2-chloro-2-methylpentan-3-yl)-2-oxodiazan-2-ium-1-olate Cyclohexyl(ethenyl)oxoammonium 1-Oxo-1,2-diazet-1-ium-2(1H)-olate 2,3-(bisbromomethyl)-4a,5,6,7,8,8a-hexahydroquinoxaline-1,4-dioxide Di-tert-butyl-nitroxid 5,6-bis(bromomethyl)-2,2-dimethyl-3-methoxy-2,3-dihydropyrazine 1,4-dioxide 2,2,5,6-tetramethyl-3-methoxy-2,3-dihydropyrazine 1,4-dioxide 3-hydroxy-2,2,5,6-tetramethyl-2,3-dihydropyrazine 1,4-dioxide 2,5-dichloro-3,6-dipropylpyrazine 1,4-dioxide 2-Chlor-1-nitrosohexadecan-Dimer 2,5-dichloro-3,6-diisobutyl-pyrazine 1,4-dioxide 2-chloro-pyrazine 1,4-dioxide N,N'-Dimethyl-glyoxaldiimin-N,N'-dioxid N,N'-diheptyldiazene N,N'-dioxide 2-methyl-2-nitrosopropane dimer [(2S)-2-chlorohexadecyl]-[[(2R)-2-chlorohexadecyl]-oxidoamino]-oxoazanium [(2R)-2-chlorohexadecyl]-[[(2R)-2-chlorohexadecyl]-oxidoamino]-oxoazanium